Payne D
Reproductive Medicine Laboratories, University of Adelaide, Queen Elizabeth Hospital, Woodville, SA, Australia.
Reprod Fertil Dev. 1995;7(4):831-9. doi: 10.1071/rd9950831.
In couples who undergo routine in vitro fertilization (IVF), 17% experience significant problems with fertilization and many others are unable to have routine IVF because the quality of their semen is too poor. Often, the only options previously available to these couples were to use sperm donated by fertile men or to remain childless. Micromanipulative assisted fertilization techniques have improved the treatment of severe male factor infertility significantly and this paper provides a brief overview of the recent methodologies. Initially, techniques such as zona drilling and partial zona dissection, in which a hole or slit is placed in the zona pellucida, demonstrated that fertilization and pregnancies could be achieved with semen of very poor quality, but successes were sporadic. Later, subzonal injection of spermatozoa provided more consistent results with many units reporting pregnancies; however, relatively low rates of fertilization (14-34%) and high rates of polyspermy remained unresolved problems. The latest technique, the injection of a single spermatozoon into the oocyte cytoplasm, although technically difficult in animal models, proved to be highly successful in the human, restoring fertilization rates to those seen in routine IVF (65%) and producing good pregnancy rates from transferred embryos. Intracytoplasmic sperm injection has become the method of choice in the treatment of severe male factor infertility and preliminary data suggest that there is no increase in congenital abnormality among babies born after the transfer of injected oocytes.
在接受常规体外受精(IVF)的夫妇中,17%的人在受精方面存在重大问题,还有许多人无法进行常规IVF,因为他们的精液质量太差。通常,这些夫妇以前唯一的选择是使用可育男性捐赠的精子或保持无子女状态。显微操作辅助受精技术显著改善了严重男性因素不孕症的治疗,本文简要概述了最近的方法。最初,诸如透明带钻孔和部分透明带切开等技术,即在透明带上开一个孔或切口,表明使用质量非常差的精液也能实现受精和怀孕,但成功案例是零星的。后来,精子卵周隙内注射提供了更一致的结果,许多单位都报告了怀孕情况;然而,受精率相对较低(14% - 34%)和多精受精率较高仍然是未解决的问题。最新技术,即向卵母细胞胞质内注射单个精子,虽然在动物模型中技术上很困难,但在人类中被证明非常成功,使受精率恢复到常规IVF中的水平(65%),并从移植胚胎中获得了良好的妊娠率。卵胞浆内单精子注射已成为治疗严重男性因素不孕症的首选方法,初步数据表明,注射后卵母细胞移植所生婴儿的先天性异常并没有增加。